 | Kiniksa to Present Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019
finance.yahoo.com - August 19 at 11:32 AM |
 | Q3 2019 EPS Estimates for Kiniksa Pharmaceuticals Ltd Boosted by Analyst (NASDAQ:KNSA)
www.americanbankingnews.com - August 15 at 7:17 AM |
| Kiniksa Pharmaceuticals (NASDAQ:KNSA) Stock Rating Reaffirmed by Wedbush
www.americanbankingnews.com - August 14 at 9:41 AM |
| Kiniksa Pharmaceuticals (NASDAQ:KNSA) Given New $35.00 Price Target at JMP Securities
www.americanbankingnews.com - August 14 at 9:35 AM |
| Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) to Post Q1 2020 Earnings of ($0.82) Per Share, Wedbush Forecasts
www.americanbankingnews.com - August 14 at 8:15 AM |
| Zacks: Analysts Expect Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) to Post -$0.76 Earnings Per Share
www.americanbankingnews.com - August 13 at 3:10 PM |
| Kiniksa Pharmaceuticals (NASDAQ:KNSA) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS
www.americanbankingnews.com - August 13 at 11:19 AM |
 | Kiniksa's KPL-716 shows encouraging action in early-stage dermatitis study
seekingalpha.com - August 12 at 8:53 PM |
| Kiniksa Announces Interim Data from KPL-716 Repeated-Single-Dose Phase 1b Clinical Trial
finance.yahoo.com - August 12 at 8:53 PM |
| Kiniksa Reports Second Quarter 2019 Financial Results and Highlights Recent Corporate and Pipeline Activity
finance.yahoo.com - August 12 at 8:53 PM |
| Kiniksa Pharmaceuticals to Present at the 2019 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 6 at 12:15 PM |
| Is Kiniksa Pharmaceuticals, Ltd. (KNSA) A Good Stock To Buy ?
finance.yahoo.com - June 30 at 10:40 AM |
| Kiniksa Presents Preclinical Data on the GM-CSF Signaling Pathway in Temporal Arteries of GCA Patients at the Annual European Congress of Rheumatology
finance.yahoo.com - June 13 at 6:32 AM |
| The Kiniksa Pharmaceuticals (NASDAQ:KNSA) Share Price Is Down 23% So Some Shareholders Are Getting Worried
finance.yahoo.com - June 10 at 12:15 PM |
| Kiniksa to Present Preclinical Data on the GM-CSF Signaling Pathway in Temporal Arteries of GCA Patients at EULAR 2019
finance.yahoo.com - May 31 at 11:39 AM |
| Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
finance.yahoo.com - May 30 at 11:44 AM |
| Kiniksa to Present Data on the Burden of Disease in Patients with Recurrent Pericarditis at the International Society for Pharmacoeconomics and Outcomes Research
finance.yahoo.com - May 16 at 9:14 AM |
| Is Pharmaceuticals, Ltd. (KNSA) A Good Stock To Buy ?
finance.yahoo.com - April 29 at 3:53 PM |
| Kiniksa to Present Clinical and Preclinical Data for KPL-716 at the 77th Annual Meeting of the Society for Investigative Dermatology
finance.yahoo.com - April 18 at 12:27 PM |
| Kiniksa to Present KPL-404 Preclinical Data at the Keystone Symposia on Antibodies as Drugs
finance.yahoo.com - April 8 at 4:19 PM |
 | Kiniksa Pharmaceuticals Ltd
www.bloomberg.com - March 19 at 10:49 AM |
| Kiniksa Presents Rilonacept Interim Phase 2 Clinical Data Poster at the American College of Cardiology’s 68th Annual Scientific Session
finance.yahoo.com - March 18 at 11:16 AM |
| Kiniksa Reports Fourth Quarter and Full-Year 2018 Financial Results and Highlights Recent Corporate and Pipeline Activity
finance.yahoo.com - March 7 at 12:40 PM |
| Kiniksa announces active U.S. IND application for Mavrilimumab
seekingalpha.com - January 3 at 11:16 AM |
| Kiniksa Pharmaceuticals to Present at 37th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 17 at 10:58 AM |
 | Kiniksa Pharmaceuticals Ltd. (KNSA) Highlights Phase 2 Clinical Data and Commences Pivotal Phase 3 Clinical Trial
www.streetinsider.com - December 12 at 3:29 PM |
| Kiniksa Announces Rilonacept Interim Phase 2 Clinical Data and Initiates Pivotal Phase 3 Clinical Trial
finance.yahoo.com - December 11 at 11:16 AM |
 | Kiniksa Pharmaceuticals Ltd.
www.barrons.com - December 10 at 3:29 PM |
| Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Update on FDA Review of Investigational NDA for Mavrilimumab in Giant Cell Arteritis
www.streetinsider.com - December 7 at 10:26 AM |
| Kiniksa Pharma down 15% on FDA hold on mavrilimumab
seekingalpha.com - December 6 at 3:31 PM |
| Kiniksa Provides Update on U.S. FDA Review of Investigational New Drug Application for Mavrilimumab in Giant Cell Arteritis
finance.yahoo.com - December 6 at 10:37 AM |
| Kiniksa Reports Third Quarter 2018 Financial Results and Pipeline Progress
finance.yahoo.com - November 1 at 9:12 AM |
| Kiniksa Pharma's KPL-716 shows encouraging action in early-stage dermatitis study
seekingalpha.com - September 17 at 3:23 PM |
| Kiniksa Presents KPL-716 Clinical Data at the 27th European Academy of Dermatology and Venereology
finance.yahoo.com - September 15 at 3:21 PM |
 | Week Ahead In Pharmaceuticals: 5 Stocks To Watch (KNSA, INCY, ANAB...)
www.finanznachrichten.de - September 9 at 7:58 AM |
| Kiniksa Pharmaceuticals to Present at the 2018 Wells Fargo Healthcare Conference
finance.yahoo.com - August 29 at 7:48 AM |
| Kiniksa to Present Late-Breaking KPL-716 Clinical Data at the 27th European Academy of Dermatology and Venereology
finance.yahoo.com - August 29 at 7:48 AM |
| Kiniksa Pharmaceuticals to Present at the 2018 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 3 at 6:54 AM |
| Kiniksa Pharmaceuticals, Ltd. Announces Exercise of the Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - June 25 at 3:16 PM |
| Kiniksa Pharmaceuticals to Present at the JMP Securities 2018 Life Sciences Conference
finance.yahoo.com - June 15 at 5:31 AM |
| Breaking Down Kiniksa Pharmaceuticals Ltd’s (NASDAQ:KNSA) Ownership Structure
finance.yahoo.com - June 12 at 3:15 PM |
| Kiniksa Pharmaceuticals, Ltd. Announces Closing of Initial Public Offering
finance.yahoo.com - June 6 at 3:15 PM |
